Waters Corporation has formally expanded its long-standing, collaborative relationship with Dr. Sunghwan Kim of Kyungpook National University to further explore the use of Waters’ cutting-edge ion mobility spectrometry (IMS) in the investigation of compounds in complex mixtures. Identifying ... more
Waters Corporation Names Udit Batra President and Chief Executive Officer
Dr. Batra succeeds Christopher O’Connell
Waters Corporation announced that Udit Batra, Ph.D. has been named the Company’s President and Chief Executive Officer, effective September 1, 2020. He will also join Waters’ Board of Directors at that time. Dr. Batra succeeds Christopher O’Connell who will remain in his current roles as President and Chief Executive Officer, and as a member of the Board until September 1, 2020. As previously announced, Mr. O’Connell will also remain with Waters as an advisor until the end of this year to support the transition.
Dr. Batra brings to Waters more than two decades of leadership and operational expertise in the healthcare and life sciences industry, including a proven track record of driving results at the top of the industry and successfully managing a global organization. Most recently, Dr. Batra served as Chief Executive Officer of the $7.7 billion Life Science business of publicly traded Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the United States and Canada. In this role, he led the business’ successful integration of Sigma-Aldrich, which was acquired in 2015, resulting in the creation of MilliporeSigma. Since that time, Dr. Batra oversaw a strategic transformation of the business and drove above-market organic sales growth and margins, which remain the highest among MilliporeSigma’s integrated peers. Prior to that, Dr. Batra served as President and Chief Executive Officer of the global Consumer Health business of Merck KGaA, Darmstadt, Germany, where he led a turnaround that almost doubled its profitability and achieved organic growth rates in the top tier of the consumer health industry.
“We are pleased to have identified such an accomplished and experienced candidate and are confident that Udit is the right leader to take Waters to the next level,” said Dr. Flemming Ornskov, Chairman of the Board. “His focus on commercial execution and innovation, proven ability to build strong and collaborative cultures and intense commitment to serving customers have translated into tangible results. Building on Waters’ strong foundation, we look forward to the Company’s next phase of innovation and growth with Udit at the helm. We are grateful for the continued hard work and leadership of Chris and the entire Waters team to remain focused on our business, continue our progress and ensure a seamless transition.”
Dr. Batra said, “As a research engineer, I have a deep knowledge of Waters and TA instruments, and I have long admired the Company and its global impact. Waters’ team of world-renowned scientists, researchers and other professionals has consistently delivered scientific and technological excellence to enhance human health and well-being. With a continued focus on organic innovation, strategic M&A and disciplined capital allocation, I am confident we will capitalize on Waters’ significant growth opportunities.”
“Throughout my career, I have focused on starting with listening and learning, embracing challenges and working with talented people. I join Waters with energy and a shared passion for technology development and serving our customers to drive value for shareholders while making the world a better place,” continued Dr. Batra.
- Udit Batra
Waters Corporation announced that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves t ... more
Waters Corporation, Prosolia, Inc. and the Purdue Research Foundation announced that Waters® acquired exclusive rights to Desorption Electrospray Ionization (DESI) technology for all mass spectrometry applications from Prosolia and PRF. "The acquisition of DESI technology bolsters Waters' p ... more
Less analyte losses due to metal interactions ✓ No time-consuming system- and column passivation ✓ Highest sensitivity, reproducibility and more stability ✓ more
Improved sensitivity, recovery and peak shape ✓ See new analytes previously undetected ✓ Increased reproducibility with less time spent on passivation more
Ever-evolving regulations are impacting LC method approaches for product quality control and beyond. Count on the Arc HPLC System for high-efficiency separations and quality data to help meet your regulatory requirements with confidence. Arc HPLC allows you to easily replicate and improve t ... more
Non-specific adsorption (NSA) of metal sensitive analytes can lead to loss of sensitivity, poor peak shape, poor reproducibility and lengthy passivation procedures. The occurrence of these NSA losses can be hard to predict and therefore, a good plan to mitigate them leads to less risk and ... more
- 1Detect neurodegenerative diseases such as Alzheimer's by a simple eye scan?
- 2Fluorescence microscopy at highest spatial and temporal resolution
- 3The Mechanics of the Immune System
- 4Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis
- 5Quick look under the skin
- 6New ion trap to create the world's most accurate mass spectrometer
- 7How does your computer smell?
- 8Clocking electron movements inside an atom
- 9Sartorius closes 2020 with strong growth
- 10A clear path to better insights into biomolecules
- LabVantage Solutions Names Digital Transformation Veteran Mikael Hagstroem a ...
- QIAGEN expands Supervisory Board with appointment of a new member
- Waters Corporation Names Udit Batra President and Chief Executive Officer
- Alexandra Knauer awarded as a female entrepreneur role model
- FRITSCH Change of Generations
- Researchers develop blood test for depression, bipolar disorder
- Doping by athletes could become tougher to hide with new detection method
- Tiny brains grown in 3D-printed bioreactor
- LabVantage Solutions Names Digital Transformation Veteran Mikael Hagstroem as Chief Executive Officer
- PerkinElmer Completes Acquisition of Oxford Immunotec